Literature DB >> 9207248

The regulation of pHi in osteoclasts is dependent on the culture substrate and on the stage of the resorption cycle.

P P Lehenkari1, T Laitala-Leinonen, T J Linna, H K Väänänen.   

Abstract

The present study was performed to clarify the role of vacuolar H+-ATPase in the regulation of the intracellular pH (pHi) in osteoclasts. Bafilomycin A1 or amiloride were added to rat osteoclast cultures to block the H+-ATPases and Na+/H+-exchangers, respectively. Addition of 10(-8) M bafilomycin A1 to osteoclasts cultured on bone induced a rapid decrease of the pHi, while addition of amiloride had only a minor effect. The response to bafilomycin A1 appeared simultaneously with resorption activity and was abolished when resorption was inhibited by calcitonin. Osteoclasts on bone recovered from acid loading caused by propionate in the presence of amiloride, while bafilomycin A1 inhibited this recovery almost completely. The pHi of osteoclasts cultured on glass responded to the addition of amiloride, but was not effected by even high concentrations of bafilomycin A1. In contrast, as little as 10(-10) M bafilomycin A1 caused accumulation of large vesicles in the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207248     DOI: 10.1006/bbrc.1997.6894

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Synergetic activation of outwardly rectifying Cl- currents by hypotonic stress and external Ca2+ in murine osteoclasts.

Authors:  H Sakai; F Nakamura; M Kuno
Journal:  J Physiol       Date:  1999-02-15       Impact factor: 5.182

2.  Calcitonin inhibits proton extrusion in resorbing rat osteoclasts via protein kinase A.

Authors:  Hiroshi Kajiya; Fujio Okamoto; Hidefumi Fukushima; Koji Okabe
Journal:  Pflugers Arch       Date:  2003-01-14       Impact factor: 3.657

3.  Skeletal affinity of Tc(V)-DMS is bone cell mediated and pH dependent.

Authors:  Kazuko Horiuchi-Suzuki; Aya Konno; Mayumi Ueda; Yoko Fukuda; Saori Nishio; Kazuyuki Hashimoto; Hideo Saji
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-11-29       Impact factor: 9.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.